XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,918,828) $ (813,096)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 44,119
Fair value of options and warrants issued in exchange for services 226,188 335,970
Fair value of restricted stock and restricted stock units issued in exchange for services 235,406
Gain on accounts payable forgiveness (402,248)
Share-based payment for settlement agreement with shareholders 279,000
Accretion of discount on notes payable 204,516
Change in fair value of warrant liability (101,744)
Change in fair value of embedded derivative liability (79,420)
Amortization and depreciation 10,894 6,331
Changes in operating assets and liabilities:    
Accounts Receivable (5,667)
Inventory (11,769) 300
Prepaid expenses (14,904)
Accounts payable and accrued expenses (80,398) 180,598
Net cash used in operating activities (1,623,303) (281,449)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of Patents (825)
Net cash used in investing activities (825)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from exercise of warrants 2,093,217 281,000
Proceeds from sale of common stock 1,154,211 531,250
Stock issuance costs (15,128)
Net cash provided by financing activities 3,247,428 797,122
NET INCREASE IN CASH AND CASH EQUIVALENTS 1,623,300 515,673
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 693,001 22,644
CASH AND CASH EQUIVALENTS - END OF PERIOD 2,316,301 538,317
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the year for: Interest
Cash paid during the year for: Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Cashless Exercise of Stock Options 4,028
Common Stock and Warrants Issued for Common Stock Payable 122,478
Deemed dividend distribution on issuance of common stock for conversion of Series C and Series D 525,630
Revaluation of embedded derivative liability upon conversion of Series C Convertible Preferred Stock 137,625
Revaluation of embedded derivative liability upon conversion of Series D Convertible Preferred Stock 11,673
Revaluation of warrant liability upon conversion of Series C Convertible Preferred Stock 189,008
Revaluation of warrant liability upon conversion of Series D Convertible Preferred Stock 43,105
Warrants issued as discount to notes payable 113,585
Conversion of accounts payable and accrued expenses to common stock 80,750
Conversion of notes payable and accrued expenses to common stock 396,101
Series A Convertible Preferred Stock [Member]    
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Convertible Preferred Stock converted to common stock 400 1,060
Series B Convertible Preferred Stock [Member]    
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Convertible Preferred Stock converted to common stock 599
Series C Convertible Preferred Stock [Member]    
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Convertible Preferred Stock converted to common stock 12,014
Revaluation of embedded derivative liability upon conversion of Series C Convertible Preferred Stock 137,625
Revaluation of warrant liability upon conversion of Series C Convertible Preferred Stock 189,008
Series D Convertible Preferred Stock [Member]    
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Convertible Preferred Stock converted to common stock 1,810
Revaluation of embedded derivative liability upon conversion of Series C Convertible Preferred Stock 11,673
Revaluation of warrant liability upon conversion of Series C Convertible Preferred Stock $ 43,105